stockrowMaravai LifeSciences Holdings, Inc.
MRVI Healthcare Biotechnology
Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024.
- Revenue
- +10.1%
- EPS
- +50.0%
- Free cash flow
- +123.9%
- Total debt
- −45.4%
Quarter to September 2026, against a year earlier
Follow MRVI
Alert me
Maravai LifeSciences Holdings, Inc. (MRVI) Free cash flow
Maravai LifeSciences Holdings, Inc.'s free cash flow for fiscal 2025 was −$70.7M, compared with −$22.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$12.5M. Over the past ten years it has ranged from −$70.7M (fiscal 2025) to $518.9M (fiscal 2022) — the current reading is the lowest in ten years. Free cash flow has fallen for 3 consecutive fiscal years. Maravai LifeSciences Holdings, Inc. ranks 173rd of 603 Biotechnology companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$70.7M | — |
| FY2024 | −$22.5M | — |
| FY2023 | $60.7M | (88.31%) |
| FY2022 | $518.9M | 46.47% |
| FY2021 | $354.3M | 119.66% |
| FY2020 | $161.3M | 2,214.90% |
| FY2019 | $7.0M | — |
| FY2018 | −$3.8M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $4.5M | 24.02% |
| Jun 2026 | $3.6M | (14.33%) |
| Mar 2026 | $4.2M | — |
| Dec 2025 | −$24.9M | — |
| 25 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. compare | $323.0M |
| SRPT Sarepta Therapeutics, Inc. compare | $176.4M |
| MRVI Maravai LifeSciences Holdings, Inc. | −$12.5M |
| TRVI Trevi Therapeutics, Inc. compare | −$52.9M |
| MESO Mesoblast Limited compare | −$84.4M |
| MAZE Maze Therapeutics, Inc. compare | −$106.8M |
| TRAX First Tracks Biotherapeutics, Inc. compare | −$112.3M |
| VIR Vir Biotechnology, Inc. compare | −$141.9M |
| REPL Replimune Group, Inc. compare | −$245.7M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)